Urinary Obstruction Clinical Trials

8 recruitingLast updated: May 13, 2026

There are 8 actively recruiting urinary obstruction clinical trials across 3 countries. Studies span Not Applicable, Phase 3, Phase 4. Top locations include Al Mansurah, Dakahlia Governorate, Egypt, Boston, Massachusetts, United States, Charlottesville, Virginia, United States. Updated daily from ClinicalTrials.gov.


Urinary Obstruction Trials at a Glance

8 actively recruiting trials for urinary obstruction are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Al Mansurah, Boston, and Charlottesville. Lead sponsors running urinary obstruction studies include Beth Israel Deaconess Medical Center, Laborie Medical Technologies Inc., and Benaroya Research Institute.

Browse urinary obstruction trials by phase

Treatments under study

About Urinary Obstruction Clinical Trials

Looking for clinical trials for Urinary Obstruction? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Urinary Obstruction trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Urinary Obstruction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Noninvasive Ultrasound Assessment of Detrusor Dysfunction

Overactive BladderBladder DysfunctionBPH With Urinary Obstruction
Mayo Clinic2,023 enrolled1 locationNCT05652023
Recruiting
Not Applicable

5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy

Prostate HyperplasiaBenign Prostatic HyperplasiaLower Urinary Tract Symptoms+5 more
Beth Israel Deaconess Medical Center120 enrolled1 locationNCT04288427
Recruiting
Not Applicable

Evaluating the Clinical Efficacy of Thulio vs. Holmium Laser Enucleation of the Prostate

BPH With Urinary ObstructionBPH With Symptomatic Lower Urinary Tract Symptoms
Smita De50 enrolled1 locationNCT07187180
Recruiting
Not Applicable

PUL vs TURP in BPH Patients With Urinary Retention

BPH With Urinary Obstruction
Queen Mary Hospital, Hong Kong100 enrolled1 locationNCT06037356
Recruiting

NXT Post-Market Clinical Follow-up

Urinary IncontinenceUrinary Bladder, NeurogenicUrinary Bladder, Overactive+2 more
Laborie Medical Technologies Inc.180 enrolled4 locationsNCT06336304
Recruiting
Not Applicable

Green LEP vs ThuLEP in Management of Marked Enlarged Prostate

Prostatic Hyperplasia With Urinary Obstruction
Mansoura University110 enrolled1 locationNCT03305861
Recruiting
Phase 3

Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP

HematuriaSame Day DischargeBPH+1 more
Northwestern University138 enrolled1 locationNCT05620784
Recruiting
Phase 4

Optimizing Pain Control in Transurethral Resection of the Prostate

PainBPH With Urinary ObstructionBPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms
Benaroya Research Institute50 enrolled1 locationNCT04102566